Shure is seeking monetary damages and multiple injunctive reliefs.
We use the implicit rate when readily determinable.
The total intrinsic value of options outstanding as of September 30, 2019 was $0.
As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.
The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2018.
The current year loss did not result in income tax benefit due to recording a full valuation allowance against expected benefits.The increase was mainly due to the increase in realized gain on sale of marketable securities.
As of September 30, 2019, our cash and cash equivalents were approximately $2.0 million compared to $11.2 million as of December 31, 2018.
9,813,806 (the “Graham Patent”).
Our revenue decreased to $18.7 million in 2019 YTD compared to $20.9 million in 2018 YTD.
The increase in cash used was primarily due to a decrease in non-cash charges of $3.4 million and increase in cash outflows due to change in operating assets and liabilities of $7.3 million which includes $4.5 million towards payment of a bond for securing the preliminary injunction in our litigation to stop the infringement of our patents, partially offset by a decrease in net loss by $7.7 million.
We believe the recent decision by the U.S. District Court in August granting our request for a preliminary injunction to prevent Shure from manufacturing, marketing, and selling its competing ceiling microphone array in an infringing configuration is an incredibly valuable ruling for ClearOne and its business.
We believe the recent decision by the U.S. District Court in August granting our request for a preliminary injunction to prevent our competitor from manufacturing, marketing, and selling its competing ceiling microphone array in an infringing configuration is an incredibly valuable ruling for ClearOne and its business.
When we capitalize patent defense costs we amortize the costs over the remaining estimated useful life of the patent, which is 15 to 17 years.
The decision validates the strength and importance of ClearOne’s intellectual property rights, recognizes ClearOne’s innovations in this space, and stops Shure from further infringing the Graham patent pending a full trial.The material weakness will be fully remediated when, in the opinion of management, the control processes have been operating for a sufficient period of time to provide reasonable assurance as to their effectiveness.9,813,806 (the “’806 Patent”).
There have been no material changes to the risk factors included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.